Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs HTEA for Myocardial Protection in CABG
NCT00244283Phase 4Unknown
- Sponsor
- Golden Jubilee National Hospital
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sevoflurane in coronary artery disease (CAD) (2 arms), sponsored by Golden Jubilee National Hospital. Primary endpoint: Plasma concentration of NT-proBNP. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00244283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244283.